Surgical Endoscopy

, Volume 26, Issue 1, pp 168–176 | Cite as

Survival and quality of life after minimally invasive esophagectomy: a single-surgeon experience

  • Abhishek Sundaram
  • Juan C. Geronimo
  • Brittany L. Willer
  • Masato Hoshino
  • Zachary Torgersen
  • Arpad Juhasz
  • Tommy H. Lee
  • Sumeet K. Mittal



Reports on quality of life (QOL) after minimally invasive esophagectomy (MIE) have been limited. This report compares perioperative outcomes, survival, and QOL after MIEs with open transthoracic esophagectomy (TTE) and open transhiatal esophagectomy (THE).


After institutional review board approval, retrospective review of a prospectively maintained database identified patients who underwent esophageal resection for esophageal cancer at Creighton University between August 2003 and August 2010. Patients with preoperative stage 4 disease, emergent procedures, laparoscopic transhiatal esophagectomies, or esophagojeujunostomies were excluded from the study. The study patients were categorized as having undergone open TTE, open THE, or MIE. Overall survival (OS) was the interval between diagnosis and death or follow-up assessment. Disease-free survival (DFS) was the interval between surgery and recurrence, death, or follow-up assessment. For the patients who survived at least 1 year after surgery, QOL was assessed using European Organization for Research and Treatment of Cancer (EORTC-QLQ, version 3.0) and esophageal module (EORTC-QLQ OES 18) questionnaires.


The study criteria were satisfied by 104 patients. Lymph node harvest with MIE (median = 20) was similar to that with open TTEs (median = 19) and significantly higher (P < 0.001) than that with open THEs (median = 12). The percentage of patients requiring intraoperative blood transfusion in the MIE group (23.4%) was significantly lower (P < 0.001) than in the open TTE (73.1%) and THE (67.7%) groups. The volume of intraoperative blood product transfusion was significantly lower for the MIE patients (median = 0 ml) than for the open TTE (median = 700 ml) and THE (median = 700 ml) patients. The incidence of respiratory complications with MIEs (10.64%) was significantly lower than with open TTEs (34.61%) and THEs (32.26%). The groups did not differ significantly in terms of R0 resection rates, OS, DFS, or QOL.


MIEs offer a safe and viable alternative to open esophagectomies because they reduce the need and volume of intraoperative blood product transfusion and postoperative respiratory complications without compromising oncological clearance, survival, and QOL.


Esophageal cancer Laparoscopic Thoracoscopic Transhiatal Transthoracic 


  1. 1.
    Orringer MB, Marshall B, Chang AC, Lee J, Pickens A, Lau CL (2007) Two thousand transhiatal esophagectomies changing trends, lessons learned. Ann Surg 246:363–374PubMedCrossRefGoogle Scholar
  2. 2.
    Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie NA, McCaughan JS, Litle VR, Schauer PR, Close JM, Fernando HC (2003) Minimally invasive esophagectomy outcomes in 222 patients. Ann Surg 238:486–495PubMedGoogle Scholar
  3. 3.
    Bailey SH, Bull DA, Harpole DH, Rentz JJ, Neumayer LA, Pappas TN, Daley J, Henderson WG, Krasnicka B, Khuri SF (2003) Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 75:217–222PubMedCrossRefGoogle Scholar
  4. 4.
    De Paula AL, Hashiba K, Ferreira EA, De Paula RA, Grecco E (1995) Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Laparosc Endosc 5:1–5PubMedGoogle Scholar
  5. 5.
    Dunst CM, Swanstrom LL (2010) Minimally invasive esophagectomy. J Gastrointest Surg 14(Suppl 1):S108–S114PubMedCrossRefGoogle Scholar
  6. 6.
    Decker G, Coosemans W, De Leyn P, Decaluwé H, Nafteux P, Van Raemdonck D, Lerut T (2009) Minimally invasive esophagectomy for cancer. Eur J Cardiothorac Surg 35:13–21PubMedCrossRefGoogle Scholar
  7. 7.
    Gao Y, Wang YY, Chen L, Zhao Y (2011) Comparison of open three-field and minimally invasive esophagectomy for esophageal cancer. Interact CardioVasc Thorac Surg 12:366–369PubMedCrossRefGoogle Scholar
  8. 8.
    Lee JM, Cheng JW, Lin MT, Huang PM, Chen JS, Lee YC (2011) Is there any benefit to incorporating a laparoscopic procedure into minimally invasive esophagectomy? The impact on perioperative results in patients with esophageal cancer. World J Surg 35:790–797PubMedCrossRefGoogle Scholar
  9. 9.
    Willer BL, Mittal SK, Worrell SG, Mumtaz S, Lee TH (2010) Applicability and feasibility of incorporating minimally invasive esophagectomy at a high-volume center. J Gastrointest Surg 14:1201–1206PubMedCrossRefGoogle Scholar
  10. 10.
    Blazeby JM, Farndon JR, Donovan J, Alderson D (2000) A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 88:1781–1787PubMedCrossRefGoogle Scholar
  11. 11.
    Lagergren P, Avery KNL, Hughes R, Barham CP, Alderson D, Falk SJ, Blazeby JM (2007) Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 110:686–693PubMedCrossRefGoogle Scholar
  12. 12.
    Parameswaran R, Blazeby JM, Hughes R, Mitchell K, Berrisford RG, Wajed SA (2010) Health-related quality of life after minimally invasive oesophagectomy. Br J Surg 97:525–531PubMedCrossRefGoogle Scholar
  13. 13.
    Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, De Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRefGoogle Scholar
  14. 14.
    Blazeby JM, Conroy T, Hammerlid E, Fayers P, Sezere O, Kollerf M, Arrarasg J, Bottomleyh A, Vickerya CW, Etiennei PL, Aldersona D, On behalf of the European Organisation for research, treatment of cancer gastrointestinal, quality of life groups (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39:1384–1394PubMedCrossRefGoogle Scholar
  15. 15.
    Djarv T, Blazeby JM, Lagergren P. Predictors of postoperative quality of life after esophagectomy for cancer. J Clin Oncol 27:1963–1968Google Scholar
  16. 16.
    Safranek PM, Cubitt J, Booth MI, Dehn TCB (2010) Review of open and minimal access approaches to oesophagectomy for cancer. Br J Surg 97:1845–1853PubMedCrossRefGoogle Scholar
  17. 17.
    Schoppmann SF, Prager G, Langer FB, Riegler FM, Kabon B, Fleischmann E, Zacherl J (2010) Open versus minimally invasive esophagectomy: a single-center case-controlled study. Surg Endosc 24:3044–3053PubMedCrossRefGoogle Scholar
  18. 18.
    Parameswaran R, Veeramootoo D, Krishnadas R, Cooper M, Berrisford R, Wajed S (2009) Comparative experience of open and minimally invasive esophagogastric resection. World J Surg 33:1868–1875PubMedCrossRefGoogle Scholar
  19. 19.
    Law S, Wong KH, Kwok KF, Chu KM, Wong J (2004) Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240:791–800PubMedCrossRefGoogle Scholar
  20. 20.
    Nguyen NT, Follette DM, Wolfe BM, Schneider PD, Roberts P, Goodnight JE (2000) Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Arch Surg 135:920–925PubMedCrossRefGoogle Scholar
  21. 21.
    Smithers BM, Gotley DC, Martin I, Thomas JM (2007) Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg 245:232–240PubMedCrossRefGoogle Scholar
  22. 22.
    Hamouda AH, Forshaw MJ, Tsigritis K, Jones GE, Noorani AS, Rohatgi A, Botha AJ (2010) Perioperative outcomes after transition from conventional to minimally invasive Ivor-Lewis esophagectomy in a specialized center. Surg Endosc 24:865–869PubMedCrossRefGoogle Scholar
  23. 23.
    Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M (2008) Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 248:221–226PubMedCrossRefGoogle Scholar
  24. 24.
    Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hölscher A, Lerut T, Law S, Rice TW, Ruol A, van Lanschot JJB, Wong J, DeMeester TR (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248:549–556PubMedCrossRefGoogle Scholar
  25. 25.
    Torgersen Z, Sundaram A, Hoshino M, Willer BL, Fang X, Tashi T, Lee TH, Mittal SK (2011) Prognostic implications of lymphadenectomy in esophageal cancer after neo-adjuvant therapy: a single-center experience. J Gastrointest Surg (in press)Google Scholar
  26. 26.
    Omloo JMT, Lagarde SM, Hulscher JBF, Reitsma JB, Fockens P, Van Dekken H, Kate FJWT, Obertop H, Tilanus HW, Van Lanschot JJB (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246:992–1001PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Abhishek Sundaram
    • 1
  • Juan C. Geronimo
    • 1
  • Brittany L. Willer
    • 1
  • Masato Hoshino
    • 1
  • Zachary Torgersen
    • 1
  • Arpad Juhasz
    • 1
  • Tommy H. Lee
    • 1
  • Sumeet K. Mittal
    • 1
  1. 1.Department of SurgeryCreighton University Medical CenterOmahaUSA

Personalised recommendations